A Lambert

Impact of primary kidney disease on the effects of empagliflozin in patients with chronic kidney disease: secondary analyses of the EMPA-KIDNEY trial

PK Judge, Natalie Staplin, KJ Mayne et al. · The Lancet Diabetes & Endocrinology · 2023 · 108 citations · Full text

Medicine, Nephrology, Pharmacotherapy +11

Effects of empagliflozin on progression of chronic kidney disease: a prespecified secondary analysis from the empa-kidney trial

Natalie Staplin, Richard Haynes, PK Judge et al. · The Lancet Diabetes & Endocrinology · 2023 · 90 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +14

In vitro activity of temocillin (BRL 17421), a novel beta-lactam antibiotic

H.W. Van Landuyt, M. Pyckavet, A Lambert et al. · Antimicrobial Agents and Chemotherapy · 1982 · 25 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +15

The Pharmacokinetics of temocillin in patients with normal and impaired renal function

Johan R. Boelaert, R Daneels, M. Schurgers et al. · Journal of Antimicrobial Chemotherapy · 1983 · 21 citations

Pharmacy, Clinical Pharmacokinetics, Pharmacokinetics +17

Effect of Renal Function and Dialysis on Temocillin Pharmacokinetics

Johan R. Boelaert, R Daneels, M. Schurgers et al. · Drugs · 1985 · 15 citations

Pharmacy, Clinical Pharmacokinetics, Pharmacokinetics +14